• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞转移后LPC-1浆细胞瘤M成分合成的暂时消失(“蚀”)

Temporary disappearance ("eclipse") of LPC-1 plasmacytoma M component synthesis following tumor cell transfer.

作者信息

Frondoza C G, Trivedi S M, Humphrey R L

出版信息

Cancer Res. 1979 Jul;39(7 Pt 1):2497-500.

PMID:445451
Abstract

The early phase of LPC-1 plasmacytoma development was studied by in vivo labeling with [6-14C]arginine using its M component (immunoglobulin G 2a,kappa) as marker. At a time when M component was not detected or faint by protein staining of electrophoretograms, significant labeling of M component was detectable by autoradiography. Labeling of the M component was fairly constant for the first 10 hr but was markedly decreased from Days 1 to 7. Nadir (0 to 3% of initial 30-min value) was observed on Day 3. Recovery of M component labeling to the 30-min level was complete by Day 13. This period of marked reduction or "eclipse" in newly synthesized M component was shortened by 2 days when mice were pretreated with pristane or cyclophosphamide prior to tumor cell transfer. The eclipse period was also 2 days shorter in athymic BALB/c-nu/nu mice than in normal BALB/c mice. The eclipse period corresponds to the classical "lag" following tumor cell transfer before tumor growth can be detected by conventional methods. The sensitivity of the [6-14C]arginine pulse permits the in vivo detection of small numbers of tumor cells (as few as 10(6) cells) over the early time periods after cell transfer. Modification of eclipse by manipulating host and/or tumor cells may elucidate the accompanying cellular and biochemical events.

摘要

利用[6-14C]精氨酸进行体内标记,并以其M成分(免疫球蛋白G 2a,κ)作为标志物,对LPC-1浆细胞瘤发展的早期阶段进行了研究。在通过电泳图谱的蛋白质染色未检测到M成分或其很微弱的时候,通过放射自显影可检测到M成分有明显的标记。在最初的10小时内,M成分的标记相当稳定,但从第1天到第7天明显减少。在第3天观察到最低点(为最初30分钟值的0至3%)。到第13天,M成分标记恢复到30分钟水平。当在肿瘤细胞转移前用 pristane 或环磷酰胺对小鼠进行预处理时,新合成的M成分显著减少或“消失”的这段时间缩短了2天。无胸腺的BALB/c-nu/nu小鼠的消失期也比正常BALB/c小鼠短2天。消失期对应于肿瘤细胞转移后在通过传统方法检测到肿瘤生长之前的经典“延迟期”。[6-14C]精氨酸脉冲的敏感性允许在细胞转移后的早期时间段内体内检测少量肿瘤细胞(低至10(6)个细胞)。通过操纵宿主和/或肿瘤细胞来改变消失期可能会阐明伴随的细胞和生化事件。

相似文献

1
Temporary disappearance ("eclipse") of LPC-1 plasmacytoma M component synthesis following tumor cell transfer.肿瘤细胞转移后LPC-1浆细胞瘤M成分合成的暂时消失(“蚀”)
Cancer Res. 1979 Jul;39(7 Pt 1):2497-500.
2
Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.通过给予环磷酰胺在移植有MOPC - 104E浆细胞瘤的小鼠的肿瘤部位和脾脏诱导出两种不同的抗肿瘤效应细胞。
J Clin Lab Immunol. 1989 May;29(1):37-43.
3
Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
Exp Hematol. 1987 Jul;15(6):715-8.
4
Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line.一种对环磷酰胺耐药的小鼠浆细胞瘤细胞系的建立与鉴定
Cancer Treat Rep. 1982 Jul;66(7):1535-44.
5
Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.环磷酰胺治疗后荷浆细胞瘤小鼠的细胞变化和抗肿瘤反应。
Cancer Res. 1985 Dec;45(12 Pt 1):6463-70.
6
Immunity against MOPC 104E plasmacytoma: effects of tumor size and time post therapy on in vivo tumor immunity.针对MOPC 104E浆细胞瘤的免疫:肿瘤大小和治疗后时间对体内肿瘤免疫的影响。
J Natl Cancer Inst. 1978 May;60(5):1107-11.
7
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
8
The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.浆细胞瘤对BALB/c小鼠血清免疫球蛋白水平的影响。
J Immunol. 1975 Feb;114(2 pt 2):793-801.
9
Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.抗肿瘤免疫在环磷酰胺诱导的皮下不可触及的MOPC - 315肿瘤排斥反应中的作用。
Cancer Res. 1982 Mar;42(3):974-9.
10
Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.环磷酰胺的杀肿瘤活性与宿主抗肿瘤免疫在治愈携带大的MOPC - 315肿瘤小鼠中的协同作用。
Cancer Res. 1981 Jun;41(6):2163-7.